Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-13

Clinical Trial Update: Early Propranolol After Traumatic Brain Injury: Phase II [Phase 2]

View source ↗

Summary

A Phase II trial evaluating early propranolol after traumatic brain injury was terminated; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Traumatic Brain Injury | Phase 2 | Status: TERMINATED | Results posted: 2016-05-13